| Date |
Speaker |
Title |
|
September 9
|
Mr. Falgun Shah
Dept of Medicinal Chemistry
University of Mississippi
|
Targeting melanocortin receptor subtype 4 for treatment of weight disorders and sexual dysfunction |
|
September 16
|
Dr. Abby Parrill
Department of Chemistry
University of Memphis
|
Targeted Intervention in Phospholipid Function
|
|
September 30
|
Mr. David Watson
Dept of Medicinal Chemistry
University of Mississippi
|
Selective TRPV1 Antagonists
|
|
October 7
|
Dr. Edward Boyer
|
TBA
|
|
October 21
|
Dr. David Rotella
|
CNS Drug Discovery: Challenges and Examples
|
|
November 4
|
Mr. Yunshan Wu
Dept of Medicinal Chemistry
University of Mississippi
|
Hypocretin (Orexin) Receptor Antagonists
|
|
November 11
|
Mr. Swapnil Kulkarni—ORP
Dept of Medicinal Chemistry
University of Mississippi
|
Design and Synthesis of Dual HMG-CoA Reductase Inhibitory, Ca+2 Channel Antagonistic Agents as Novel Treatments for Cardiovascular Disease
|
|
November 18
|
Mr. Robert Smith—ORP
Dept of Medicinal Chemistry
University of Mississippi
|
Design, Synthesis, and Biological Evaluation of Granzme A
Inhibitors: Implications in Alzhiemer's
|
|
December 2
|
Ms. Andrekus (Missy) Lee
Dept of Medicinal Chemistry
University of Mississippi
|
Allosteric Modulation: A Novel Approach To Drug Discovery
|
|
TBA
|
Dr. David Graves
|
TBA
|